Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

Published:2023-08 Issue:8 Volume:23 Page:974-982
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Kimathi Derick,Juan-Giner Aitana,Orindi Benedict,Grantz Kyra H,Bob Ndeye S,Cheruiyot Stanley,Hamaluba Mainga,Kamau Naomi,Fall Gamou,Dia Moussa,Mosobo Moses,Moki Felix,Kiogora Kenneth,Chirro Oscar,Thiong'o Alexander,Mwendwa Jane,Guantai Andrew,Karanja Henry K,Gitonga John,Mugo Daisy,Ramko Kelly,Faye Ousmane,Sanders Eduard J,Grais Rebecca F,Bejon Philip,Warimwe George M

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. Severe yellow fever in Brazil: clinical characteristics and management;Ho;J Travel Med,2019

2. Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection;Staples;npj Vaccines,2020

3. Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial;Juan-Giner;Lancet,2021

4. Fact sheet—Latest global and regional statistics on the status of the AIDS epidemic,2022

5. Kenya AIDS strategic framework 2014/2015–2018/2019,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accumulating evidence on the long-term immunogenicity of fractional dosing for yellow fever vaccines;The Lancet Infectious Diseases;2024-06

2. Immunological response to fractional-dose yellow fever vaccine administered during an outbreak in Kinshasa, Democratic Republic of the Congo: results 5 years after vaccination from a prospective cohort study;The Lancet Infectious Diseases;2024-06

3. YF17D‐based vaccines – standing on the shoulders of a giant;European Journal of Immunology;2024-04-03

4. Immune response induced by standard and fractional doses of 17DD yellow fever vaccine;npj Vaccines;2024-03-08

5. Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A Perspective;Infection and Drug Resistance;2023-11